InChI=1S/C25H46NO7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-25(28)33-24(22-27)23-32-34(29,30)31-21-20-26/h9-10,12-13,15-16,24,27H,2-8,11,14,17-23,26H2,1H3,(H,29,30)/b10-9-,13-12-,16-15-/t24-/m1/s1 |
FJDVENKXPUIXRG-WMTBOZPISA-N |
C([C@@H](CO)OC(CCC/C=C\C/C=C\C/C=C\CCCCCCCC)=O)OP(=O)(OCCN)O |
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via 2-acyl-sn-glycero-3-phosphoethanolamine )
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via lysophosphatidylethanolamine 20:3 )
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
(via 2-acyl-sn-glycero-3-phosphoethanolamine )
|
|
View more via ChEBI Ontology
Outgoing
|
2-[(5Z,8Z,11Z)-icosatrienoyl]-sn-glycero-3-phosphoethanolamine
(CHEBI:90579)
has functional parent
(5Z,8Z,11Z)-icosatrienoic acid
(CHEBI:72865)
2-[(5Z,8Z,11Z)-icosatrienoyl]-sn-glycero-3-phosphoethanolamine
(CHEBI:90579)
has role
mouse metabolite
(CHEBI:75771)
2-[(5Z,8Z,11Z)-icosatrienoyl]-sn-glycero-3-phosphoethanolamine
(CHEBI:90579)
is a
2-acyl-sn-glycero-3-phosphoethanolamine
(CHEBI:28936)
2-[(5Z,8Z,11Z)-icosatrienoyl]-sn-glycero-3-phosphoethanolamine
(CHEBI:90579)
is a
lysophosphatidylethanolamine 20:3
(CHEBI:72735)
|
|
(2R)-1-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxypropan-2-yl (5Z,8Z,11Z)-icosa-5,8,11-trienoate
|
(5Z,8Z,11Z-Eicosatrienoyl)-lysophosphatidylethanolamine
|
HMDB
|
2-[(5Z,8Z,11Z)-eicosatrienoyl]-sn-glycero-3-phosphoethanolamine
|
ChEBI
|
LPE(0:0/20:3)
|
HMDB
|
LPE(0:0/20:3n9)
|
HMDB
|
LPE(0:0/20:3w9)
|
HMDB
|
LPE(20:3)
|
HMDB
|
lyso-PE(0:0/20:3)
|
HMDB
|
lyso-PE(0:0/20:3n9)
|
HMDB
|
lyso-PE(0:0/20:3w9)
|
HMDB
|
lyso-PE(20:3)
|
HMDB
|
LysoPE(0:0/20:3(5Z,8Z,11Z))
|
ChEBI
|
LysoPE(0:0/20:3)
|
HMDB
|
LysoPE(0:0/20:3n9)
|
HMDB
|
LysoPE(0:0/20:3w9)
|
HMDB
|
LysoPE(20:3)
|
HMDB
|
Lysophosphatidylethanolamine(0:0/20:3)
|
HMDB
|
Lysophosphatidylethanolamine(0:0/20:3n9)
|
HMDB
|
Lysophosphatidylethanolamine(0:0/20:3w9)
|
HMDB
|
Lysophosphatidylethanolamine(20:3)
|
HMDB
|
25114169
|
PubMed citation
|
Europe PMC
|
27471436
|
PubMed citation
|
Europe PMC
|
|